Pseudoallergic reactions to food additives and non-steroidal antiinflammatory drugs;Nahrungsmitteladditivia und nicht-steroidale antiphlogistika - Ausloser von pseudoallergischen reaktionen

Allergologie

Volumn 19, Issue 10, 1996, Pages 442-448

  Czech, W ^a,c   Busse, A ^a   Wedi, B ^b   Kapp, A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NONE   (Germany)

Author keywords

diagnosis; food additives; non steroid antiinflammatory drugs; pathophysiology; pseudoallergy

Indexed keywords

ACETYLSALICYLIC ACID; COMPLEMENT; HISTAMINE; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT;

CHRONIC URTICARIA; COLD; DRUG HYPERSENSITIVITY; FOOD ALLERGY; HUMAN; PATHOPHYSIOLOGY; REVIEW;

EID: 0029830714     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Ameisen J.C., A. Capron, M. Joseph, J. Maclouf, H. Vorng, V. Pancre: Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthmatic attacks. Diagnostic and physiopathological implication. Int. Arch. All. Appl Immunol. 78, 438-448 (1985).
2. Angelini J.F. G.P. Leonardos: Food-additives - some economic considerations. Food Technol. 24, 40-50 (1973).
3. Arm J P., T.H. Lee. Sulfidopeptide leukotrienes in asthma. Clin. Sci. 84, 501-510 (1993).
4. Barnes P.J., K.F. Chung, C.P. Page: Inflammatory mediators. In: Page C.P., P.J. Barnes: Pharmacology of asthma. Handbook of Experimental Pharmacology. Springer, Berlin 1991, 65-69.
5. Bosso J.V., L.B. Schwartz, D.D. Stevenson: Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88, 830-837 (1991).
6. Brown B.L., S.G. Harner, R.G. Van Dellen: Nasal polypectomy in patients with asthma and sensitivity to aspirin. Arch. Otolaryngol. 105, 413-416 (1979).
7. Busse A., W. Czech: Erarbeitung von Verfahren zur in-vitro Diagnostik bei pseudoallergischen Reaktionen auf Nahrungsmitteladditiva. Jahresbericht 5. Statuskolloquium PUG. Kemforschungszentrum, Karlsruhe 1996.
8. Christi P.E., P. Tagari, A.W. Ford-Hutchinson: Urinary LTE4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am. Rev. Respir. Dis. 145, 1025-1029 (1991).
9. Christie P.E., C.M. Smith, T.H. Lee: The potent and selective sulfidopeptide leukotriene antagonist, SK and F104353, inhibits aspirin-induced asthma. Am. Rev. Respir. Dis. 144, 957-958 (1991).
10. Commission of the European Communities: Food science and techniques. Report of the Scientific Committee for Food. Report of a working group on adverse reactions to ingested additives. Twelfth Series, 1982.
11. Coombs R.R.A., P.G.H. Gell: The classification of allergic reactions underlying disease. In: Gell P.G.H., R.R.H. Coombs: Clinical aspects of immunology. Davis. Philadelphia 1963, 317.
12. Czarnetzki B.M.: Urtikaria. Springer, Berlin 1986, 96-108.
13. Czech W., A. Kapp, E. Kownatzki, E. Schöpf: Die Bedeutung der in-vitro-induzierten Histaminfreisetzung aus isolierten Leukozyten für die Diagnostik pseudoallergischer Reaktionen auf Acetylsalicylsaure. Allergologie 13, 201-204 (1990).
14. Czech W., E. Schöpf, A. Kapp: Granulocyte mediator release in pseudo-allergic reactions In: Ring J.. B Przybilla: New trends in allergy III. Springer, Berlin 1991, 311-317.
15. Czech W., E. Schöpf, A Kapp: Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudo-allergy to acetylsalicylic acid. Inflamm. Res. 44, 291-295 (1995).
16. Dahlen B., M. Kumlin, D.J. Margoleskee: The leukotriene-receptor antagonits Mk-0679 blocks airway obstruction induced by bronchial provocation with lysme-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 7, 1018-1026 (1993).
17. Dekker J.W., K. Pile, E. Nizankowska: An analysis of the association between aspirin-induced asthma (AIA) and HLA class II system. Eur. Respir. J. 7, 276s (1994).
18. Delany J.C.: The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin. Allergy 6, 177-181 (1976).
19. Dukor P., P. Kallos, H.D. Schlumberger, G.B. West: PAR, pseudoallergic reactions. Involvement of drugs and chemicals. Karger, Basel 1980 und 1982.
20. Ferreri N.R., W.C. Howland, D.D. Stevenson, H.L. Spiegelberg: Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am. Rev. Respir. Dis. 137, 847-854 (1988).
21. Fischer A.R., M.A. Rosenberg, C.M. Lilly, J.C. Callery: Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J. Allergy Clin. Immunol. 94, 1046-1056 (1994).
22. Fuglsang G., C. Madsen, P. Saval, O. Osterballe: Prevalence of intolerance to food additives among danish school children. Pediatr. Allergy Immunol. 4, 123-129 (1993).
23. Fuglsang G., C. Madsen, S. Halken, M. Jorgensen, P.A. Ostergaard, O. Osterballe: Adverse reactions to food additives in children with atopic symptoms. Allergy 49, 31-37 (1994).
24. Genton C, PC. Frei, A. Pecoud: Value of oral provocation tests to aspirin and food additives in the routine investigation of asthma and chronic urticaria. J. Allergy Clin. Immunol. 76, 40-45 (1985).
25. Gerber J.G., N.A Payne, O. Oelz, A.S. Nies, J.A. Oates: Tartrazin and the prostaglandin system. J. Allergy Clin. Immunol. 63, 289 (1979).
26. Hänsch G.M., V. Voigtländer, U. Rather: Effect of aspirin on the complement system in vitro. Int. Arch. Allergy Appl. Immunol. 61, 150 (1980).
27. Henderson W.R.: The role of leukotrienes in inflammation Ann. Intern. Med. 121, 689-697 (1994).
28. Hirschberg V.: Mitteilung über einen Fall von Nebenwirkung des Aspirin. Dtsch. Med. Wschr. 28, 416 (1902).
29. Hosemann W.G., H W. Baenkler, F. Günther: ASA-induced release of histamine from nasal mucos membranes in analgesic intolerance and polyposis nasi. Rhinology 28, 231-238 (1990).
30. Israel E., R.A. Fischer, M.A. Rosenberg: The pivotal role of 5-lipoxygenase in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148, 1447-1451 (1993).
31. Jones D H., A.G. May, J.J. Condemi: HLA DR typing of aspirin-sensitive asthmatics. Ann. Allergy 52, 87 (1984).
32. Juhlin L., G. Michaelsson, O. Zetterström: Urticaria and asthma induced by food and drug additives in patients with aspirin hypersensitivity. J. Allergy Clin. Immunol. 50, 92 (1972).
33. Juhlin L: Intolerance to food and drug additives. In: De Weck A.L., H. Bundgaard: Allergic reactions to drugs. Springer, Berlin 1983, 639-655.
34. Juhlin L.: Food additives in urticaria. In: Champion R.H., M.W. Greaves, A. Kobza-Black, R.J. Pye: The urticarias. Churchill Livingstone, Edinburgh 1985, 189-197.
35. Kallos P., H.D. Schlumberger: Pseudo-allergic reactions. Int. Arch. Allergy Appl. Immunol. 82, 1-3 (1987).
36. Kapp A., W. Czech, J. Krutmann, E. Schöpf: Eosinophil cationic protein in sera of patients with atopic dermatitis. J. Am. Acad. Dermatol. 24, 555-558 (1991).
37. Kowalski M.L.: Aspirin-sensitive rhinosinusitis/asthma syndrome - pathophysiology and management. J. Allergy Clin. Immunol. 8, 49-56 (1996).
38. Kowalski M.L., J. Grzegorczyk, B. Wojciechowska: Influx and activation of eosinophils (EOS) in nasal secretions after local challenge with aspirin (ASA) in ASA-sensitive patients. J. Allergy Clin. Immunol. 91, 192 (1993).
39. Kowalski M.L., J. Grzegorczyk, B. Wojciechowska, M. Poniatowska: Intranasal challange with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin. Exp. Allergy (in press).
40. Kowalski M.L., J. Grzegorczyk, R. Pawliczak, J. Wozniak: In vitro generation of eosinophil chemotactic activity (ECA) by nasal polyps from ASA-sensitive and ASA-tolerant patients. J. Allergy Clin. Immunol. 95, 337 (1995).
41. Kumllin M., B. Dahlen, T. Bjorck: Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4 and histamine in asthmatics. Am. Rev. Respir. Dis. 146, 96-103 (1992).
42. Lenz P., W. Czech, E. Schöpf, A Kapp: Eosinophils - crucial target cells in pseudoallergic reactions to acetylsahcylic acid? Arch. Dermatol. Res. 286, 223 (1994).
43. Lackey R.F., D.L. Rucknagel, N.A. Vanselow: Familial occurence of asthma, nasal polyps and aspirin intolerance. Ann. Int. Med. 78, 57 (1973).
44. Lumpany A., I. Welsh, E. Christie: An analysis with sequence-specific oligonucleotide probes of the association between aspirin-induced asthma and antigens of the HLA-system. J. Allergy Clin. Immunol. 92, 114-123 (1993).
45. Malmgren R., G. Urge, O. Zetterström, H. Theorell, K. de Wahl: Lowered gluthathione-peroxidase activity in asthmatic patients with food and aspirin intolerance. Allergy 41, 43-45 (1986).
46. Maur v. K., N.F. Adkinson, T.E. van Metre, D.G. Marsh, P.S. Norman: Aspirin intolerance in a family. J. Allergy Clin. Immunol. 54, 380 (1974).
47. Meade E.A., W.L. Smith, D.L. De Witt: Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other anti-inflammatory drugs. J Biol. Chem. 268, 6610-6614 (1993).
48. Merk H.F.: Allergische Arzneimittelreaktionen der Haut. In: Merk H.F.: Allergische und pseudoallergische Arzneimittelreaktionen. Blackwell. Berlin 1993, 2.
49. Moloney J.R.: Nasal polyps, nasal polypectomy, asthma and aspirin sensitivity. Their association in 445 cases of nasal polyps. J. Laryngol. Otol. 91, 837-846 (1977).
50. Mullarkey M.F., P.C. Thomas, J.A. Hansen: Association of aspirin-sensitive asthma with HLA-DQw2. Am. Rev. Respir. Dis. 133, 261 (1986).
51. Murdoch R.D., I. Pollock, E. Young: Food additive-induced urticaria: studies of mediator release during provocation tests. J. Roy. Coll. Phys. 21, 262-266 (1987).
52. Murdoch R.D., I. Pollock, S. Naem: Tartrazin induced histamine release in vivo in normal subjects. J. Roy. Coll. Phys. 21, 257-261 (1987).
53. Okuda Y., H. Hattori, T. Takashima, A. Miyatake, A. Ymatodai, I. Tsuyuguchi: Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma. J. Allergy Clin. Immunol. 86, 548-553 (1990).
54. Ortolant C., E. Pastorello, M. T. Luraghi, F. Della Torre, M. Bellani, C. Zanussi: Diagnosis of intolerance to food additives. Ann. Allergy 53, 587-591 (1984).
55. Patriarca G., A. Romano, D. Schiavino, A. Venuti, V. DiRienzo, G. Fais, E. Nucera: ASA disease: the clinical relationship of nasal polyposis to ASA intolerance. Arch. Otorhinolaryngol. 243, 16-19 (1986).
56. Pawlowicz A., WR. Williams, B.H. Davies: Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma. Allergy 46, 405-409 (1991).
57. Picado C., J.A. Castillo, J.M. Montserrat, A. Agussti-Vidal: Aspirin-intolerance: a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur. Resp. J. 2, 127-129 (1989).
58. Pleskow W.W., D.D. Stevenson, D.A. Mathison: Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J. Allergy Clin. Immunol. 69, 11-19 (1982).
59. Ring J.: Pseudoallergische Arzneimittelreaktionen. In: Ring J.: Angewandte Allergologie. MMV Medizin-Verlag. München 1988, 223-234.
60. Ring J: Nahrungsmittelallergien und andere nahrungsmittel-bedingte Unvertraglichkeitsreaktionen. Aktuelle Ernährungsmedizin 14, 49-56 (1989).
61. Schapowal A.G., H.-U. Simon, M. Schmitz-Schumann: Phenomenology, pathogenesis. diagnosis and treatment of aspirin-sensitive rhinosinusitis. Acta Otol Rhinol. Laryngologica 49, 235-250 (1995).
62. Schlumberger H.D.: Pseudoallergische Reaktionen gegen Arzneimittel. In: Merk H.F.: Allergische und pseudoallergische Arzneimittelreaktionen. Blackwell, Berlin 1993, 77-86.
63. Schlumberger H.D., E.A. Löbecke, P. Kallos: Acetylsalicylic acid intolerance. Lack of N-acetylsalicylic acid specific skin-sensitizing antibodies in the serum of intolerant individuals. Acta. Med. Scand. 196, 451 (1974).
64. Samter M., R.F. Beers: Concerning the nature of intolerance to aspirin. J. All. 40, 281-293 (1967).
65. Samter M., R.F. Beers: Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68, 975-983 (1968).
66. Settipane G.A.: Aspirin and allergic diseases. Am. J. Med. 74, 102-110 (1983).
67. Settipane G.A., R.K. Puddupakkam: Aspirin intolerance. III. subtypes, familial occurence. and cross-reactivity with tartrazine. J. Allergy Clin. Immunol. 56, 215 (1975).
68. Simon R., W.W. Pleskow, M. Kaliner: Plasma mediators studied in aspirin sensitive asthma: lack of role for mast cells. J. Allergy Clin. Immunol. 71, 143 (1983).
69. Stevenson D.D., R.A. Simon, W.R. Lumry, D.A. Mathison: Adverse reactions to tartrazine. J. Allergy Clin. Immunol. 78, 182-191 (1986).
70. Stevenson D.D., C.M. Arroyave, K.N. Bhat, N.M. Tan: Oral aspirin challange in asthmatic patients: a study of plasma histamine. Clin. Allergy 6, 493-506 (1976).
71. Szczelik A.: Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann. Allergy 59, 113-118 (1987).
72. Szezelik A.: Aspirin-induced asthma as a viral disease. Clin. Allergy 18, 15-20 (1988).
73. Szczelik A., G. Gryglewski, G. Czerniawska-Mysik: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J. 1, 67-69 (1975).
74. Szczelik A., R.J. Gryglewski, G. Czerniawska-Mysik: Clinical patterns of hypersensitivity to non-steroidal antiinflammatory drugs and their pathogenesis. J. Allergy Clin. Immunol. 60, 276-284 (1977).
75. Szmidt M., I. Grzelewska-Rzymowska, J. Rozniecki, M. Kowalski, I. Rychlicka: Histaminemia after aspirin challenge in aspirin-sensitive asthmatics. Agents Actions 11, 105-107 (1981).
76. Vane J.: Towards a better aspirin. Nature 367, 215-216 (1994).
77. Votgtländer V., G.M. Hünsch, U. Rother: Effect of aspirin on the complement system in vivo. Int. Arch. Allergy Appl. Immunol. 61, 145 (1980).
78. Votgtländer V., G. Hänsch, U. Rother: Acetylsalicylic acid intolerance: a possible role of complement. Int. Arch. Allergy Appl. Immunol. 66 (Suppl. 1), 154-155 (1981).
79. Wedi B., A. Kapp: Erarbeitung von Verfahren zur in-vitro Diagnostik bei pseudoallergischen Reaktionen auf Nahrungsmitteladditiva. Jahresbericht 5. Staruskolloquium PUG. Kernforschungszentrum, Karlsruhe 1996.
80. West G.B.: Dextran intolerance in rats. Ref. 19, 108 (1980).
81. Wellbrock M., J Mertens, M. Cornelius, J. Brasch: Intranasale Provokation mit Lysinacetylsalicylsäure. HNO 41, 577-581 (1993).
82. Wüthrich B., L. Fabro: Acetylsalicylsäure-und Lebensmitteladditiva-Intoleranz bei Urtikaria. Asthma bronchiale und chronischer Rhinopathie. Schweiz. Med. Wschr. 111, 1445-1450 (1981).
83. Young E., S. Patel, M. Stoneham: The prevalence of reaction to food additives in a survey population. J. R. Coll. Physicans 21, 241-247 (1987).
84. Yurchak A.M., K. Wicher, C.E. Arbesman: Immunologic studies on aspirin. J. Allergy 46, 245-253 (1970).
85. Zuberbier T., S Chantraine-Hess, K. Hartmann, B.M. Czarnetzki: Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm. Venerol. 75, 484-487 (1995).